Fayad Leonardo, Narciso-Schiavon Janaína Luz, Lazzarotto César, Ronsoni Marcelo Fernando, Wildner Letícia Muraro, Bazzo Maria Luiza, Schiavon Leonardo de Lucca, Dantas-Corrêa Esther Buzaglo
Department of Internal Medicine, Division of Gastroenterology, Federal University of Santa Catarina (UFSC). Brazil.
Department of Clinical Analysis, Federal University of Santa Catarina (UFSC). Brazil.
Ann Hepatol. 2015 Jan-Feb;14(1):83-92.
Although several prognostic models have been proposed for cirrhotic patients listed for transplantation, the performance of these scores as predictors of mortality in patients admitted for acute decompensation of cirrhosis has not been satisfactorily investigated.
To study MELD, MELD-Na, MESO, iMELD, Refit-MELD and Refit MELD-Na models as prognostic predictors in cirrhotic patients admitted for acute decompensation, and to compare their performance between admission and 48 hours of hospitalization to predict in-hospital mortality.
This cohort study included cirrhotic patients admitted to hospital due to complications of the disease. Individuals were evaluated on admission and after 48 h of hospitalization, and mortality was evaluated during the present admission.
One hundred and twenty-three subjects with a mean age of 54.26 ± 10.79 years were included; 76.4% were male. Mean MELD score was 16.43 ± 7.08 and 52.0% of patients were Child-Pugh C. Twenty-seven patients (22.0%) died during hospitalization. Similar areas under the curve (AUROCs) for prognosis of mortality were observed when different models were compared on admission (P > 0.05) and after 48 h of hospitalization (P > 0.05). When models executed after 48 h of hospitalization were compared to their corresponding model calculated on admission, significantly higher AUROCs were obtained for all models (P < 0.05), except for MELD-Na (P = 0.075) and iMELD (P = 0.119).
The studied models showed similar accuracy as predictors of in-hospital mortality in cirrhotic patients admitted for acute decompensation. However, the performance of these models was significantly better when applied 48 h after admission when compared to their calculation on admission.
尽管已经针对列入移植名单的肝硬化患者提出了几种预后模型,但这些评分作为肝硬化急性失代偿患者死亡率预测指标的表现尚未得到令人满意的研究。
研究终末期肝病模型(MELD)、MELD-钠模型、改良终末期肝病模型(MESO)、即时MELD(iMELD)、重新调整的MELD模型和重新调整的MELD-钠模型作为肝硬化急性失代偿患者预后预测指标的情况,并比较它们在入院时和住院48小时时预测院内死亡率的表现。
这项队列研究纳入了因疾病并发症入院的肝硬化患者。在入院时和住院48小时后对个体进行评估,并评估本次住院期间的死亡率。
纳入了123名平均年龄为54.26±10.79岁的受试者;76.4%为男性。平均MELD评分为16.43±7.08,52.0%的患者为Child-Pugh C级。27名患者(22.0%)在住院期间死亡。在入院时(P>0.05)和住院48小时后(P>0.05)比较不同模型时,观察到死亡率预后的曲线下面积(AUROC)相似。当将住院48小时后执行的模型与其入院时计算的相应模型进行比较时,除MELD-钠模型(P=0.075)和iMELD(P=0.119)外,所有模型均获得了显著更高的AUROC(P<0.05)。
所研究的模型作为肝硬化急性失代偿患者院内死亡率预测指标显示出相似的准确性。然而,与入院时计算相比,这些模型在入院48小时后应用时的表现明显更好。